1887

Abstract

The prevalence of two types of Epstein-Barr virus (EBV) in Japan was studied by using the polymerase chain reaction (PCR). The U2 region encoding EBV nuclear antigen 2 (EBNA-2) was chosen as the target of amplification. Consensus primers were synthesized from sequences common to the two types but encompassing a large stretch of deletion in the sequence of type 1 EBV. The primers were capable of amplifying both types at the same time but allowed differentiation of each type by the size of the amplification products. Thus we could carry out detection and typing of EBV in a one-step PCR. EBV was detected in mouth washings of 21 (23%) of 91 seropositive healthy adults. Twenty samples (22%) contained type 1 and only one (1%) type 2. Seventy-nine patients suffering from various types of tonsillitis were also studied. EBV was detected in mouth washings of 37 patients (47%). Thirty-four (43%) contained type 1 and three (4%) type 2. Double infection was not seen in either healthy donors or patients. These results indicate that type 1 EBV is highly dominant and the type 2 variant is quite rare in Japan.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-2-455
1992-02-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/2/JV0730020455.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-2-455&mimeType=html&fmt=ahah

References

  1. Adldinger H. K., Delius H., Freese U. K., Clarke J., Bornkamm G. W. 1985; A putative transforming gene of Jijoye virus differs from that of Epstein–Barr virus prototypes. Virology 141:221–234
    [Google Scholar]
  2. Berger J. 1969; IgA glomerular deposits in renal disease. Transplantation Proceedings 1:939–944
    [Google Scholar]
  3. Chang Y. S., Tyan Y. S., Liu S. T., Tsai M. S., Pao C. C. 1990; Detection of Epstein–Barr virus DNA sequences in nasopharyngeal carcinoma cells by enzymatic DNA amplification. Journal of Clinical Microbiology 28:2398–2402
    [Google Scholar]
  4. Crouse C. A., Pflugfelder S. C., Cleary T., Demick S. M., Atherton S. S. 1990; Detection of Epstein–Barr virus genomes in normal human lacrimal glands. Journal of Clinical Microbiology 28:1026–1032
    [Google Scholar]
  5. Dambaugh T., Hennessy K., Chamnankit L., Kieff E. 1984; U2 region of Epstein–Barr virus DNA may encode Epstein–Barr nuclear antigen 2. Proceedings of National Academy of Sciences, U.S.A. 81:7632–7636
    [Google Scholar]
  6. Epstein M. A., Achong B. G., Barr Y. M. 1964; Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet i:702–703
    [Google Scholar]
  7. Fox R. I., Pearson G., Vaughan J. H. 1986; Detection of Epstein–Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren’s syndrome. Journal of Immunology 137:3162–3168
    [Google Scholar]
  8. Gopal M. R., Thomson B. J., Fox J., Tedder R. S., Honess R. W. 1990; Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet i:1598–1599
    [Google Scholar]
  9. Gratama J. W., Oosterveer M. A. P., Klein G., Ernberg I. 1990; EBNA size polymorphism can be used to trace Epstein–Barr virus spread within families. Journal of Virology 64:4703–4708
    [Google Scholar]
  10. Greenspan J. S., Greenspan D., Lennette E. T., Abrams D. I., Conant M. A., Petersen V., Freese U. K. 1985; Replication of Epstein–Barr virus within the epithelial cells of oral ‘hairy’ leukoplakia, an AIDS-associated lesion. Vcw England Journal of Medicine 313:1564–1571
    [Google Scholar]
  11. Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., Osato T. 1990; Epstein–Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet i:128–130
    [Google Scholar]
  12. Hayashi Y., Tabata T. 1988; Immunological studies on the relation between tonsil and pustulosis palmaris et plantaris. Acta oto-laryngologica (supplement) 454227–236
    [Google Scholar]
  13. Henle W., Henle G. 1982; Immunology of Epstein–Barr virus. Comprehensive Virology 1:209–252
    [Google Scholar]
  14. Henle W., Henle G. 1985; Epstein–Barr virus and human malignancies. Advances in Viral Oncology 5:201–238
    [Google Scholar]
  15. Kuki K., Tabata T. 1988; Immunological studies on tonsils of recurrent tonsillitis and tonsils with focal infections. Acta otolaryngologica (supplement) 45475–82
    [Google Scholar]
  16. Kure S., Kikuchi Y., Yoshie O. 1986; Enzyme-linked immunosorbent assay for detection of antibodies to Epstein–Barr virus-associated nuclear antigen-1 using a synthetic oligopeptide. Microbiology and Immunology 30:831–836
    [Google Scholar]
  17. Leyvraz S., Henle W., Chahinian P. A., Perlmann C., Klein G., Gordon R. E., Rosenblum M., Holland J. F. 1985; Association of Epstein–Barr virus with thymic carcinoma. New England Journal of Medicine 312:1296–1299
    [Google Scholar]
  18. Masuda Y., Terazawa K., Kawakami S., Oguro Y., Sugiyama N. 1988; Clinical and immunological study of IgA nephropathy before and after tonsillectomy. Acta oto-laryngologica (supplement) 454248–255
    [Google Scholar]
  19. Rickinson A. B., Young L. S., Rowe M. 1987; Influence of the Epstein–Barr virus nuclear antigen EBNA2 on the growth phenotype of virus-transformed B cells. Journal of Virology 61:1310–1317
    [Google Scholar]
  20. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. I., Mullis K. B., Erlich H. A. 1988; Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487–491
    [Google Scholar]
  21. Saito L., Servenius B., Compton T., Fox R. I. 1989; Detection of Epstein–Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren’s syndrome. Journal of Experimental Medicine 169:2191–2198
    [Google Scholar]
  22. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual 2nd edn New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  23. Sixbey J. W., Shirley P., Chesney P. J., Buntin D. M., Resnick L. 1989; Detection of a second widespread strain of Epstein–Barr virus. Lancet ii:761–765
    [Google Scholar]
  24. Skare J., Farley J., Strominger J. L., Fresen K. O., Cho M. S., zur Hausen H. 1985; Transformation by Epstein–Barr virus requires DNA sequences in the region of BamHI fragments Y and H. Journal of Virology 55:286–297
    [Google Scholar]
  25. Takada K., Horinouchi K., Ono Y., Aya T., Osato T., Takahashi M., Hayasaka S. 1991; An Epstein–Barr virusproducer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5:147–156
    [Google Scholar]
  26. Telenti A., Marshall W. F., Smith T. F. 1990; Detection of Epstein–Barr virus by polymerase chain reaction. Journal of Clinical Microbiology 28:2187–2190
    [Google Scholar]
  27. Thomsen K., Osterbye P. 1973; Pustulosis palmaris et plantaris. British Journal of Dermatology 89:293–297
    [Google Scholar]
  28. Wang F., Gregory C. D., Rowe M., Rickinson A. B., Wang D., Birkenbach M., Kikutani H., Kishimoto T., Kieff E. 1987; Epstein–Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proceedings of the National Academy of Sciences, U.S.A. 84:3452–3456
    [Google Scholar]
  29. Weiss L. M., Strickler J. G., Warnke R. A., Purtilo D. T., Sklar J. 1987; Epstein–Barr viral DNA in tissues of Hodgkin’s disease. American Journal of Pathology 129:86–91
    [Google Scholar]
  30. Young L. S., Yao Q. Y., Rooney C. M., Sculley T. B., Moss D. J., Rupani H., Laux G., Bornkamm G. W., Rickinson A. B. 1987; New type B isolates of Epstein–Barr virus from Burkitt’s lymphoma and from normal individuals in endemic areas. Journal of General Virology 68:2853–2862
    [Google Scholar]
  31. Zimber U., Adldinger H. K., Lenoir G. M., Vuillaume M., Knebel-Doeberitz M. V., Laux G., Desgranges C., Wittmann P., Freese U. -K., Schneider U., Bornkamm G. W. 1986; Geographical prevalence of two types of Epstein–Barr virus. Virology 154:56–66
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-2-455
Loading
/content/journal/jgv/10.1099/0022-1317-73-2-455
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error